药物引起的肺损伤分析文件：大数据分析的专家意见

English | 2024 | ISBN: 9819734452 | 173 Pages | PDF EPUB (True) | 14 MB

This book describes the pathologic conditions of drug-induced lung injuries, monitoring strategies, and guides on how to interpret the evidence. It also dives into particular drugs that caused the disorder, such as EGFR inhibitors, anti-EGFR antibodies, mTOR inhibitors, proteasome inhibitors, immune checkpoint inhibitors, neoangiogenesis inhibitors, and other molecular targeted drugs. It outlines the analysis and interpretation of the post-marketing survey on surveillance of each drug for inducing pulmonary lesions presenting diffuse haziness. The data and analysis from this survey are valuable since a guideline is yet to be established due to limited clinical evidence and cases. As new drugs are developed, establishing treatment and event management is crucial. Thus, Drug-induced Pulmonary Disorder in Medical Oncology - Expert Opinion to Decipher Big Data summarizes the accumulated information to provide a foundation for further research advancement. The book offers a refreshing alternative to current approaches to medical oncology and respiratory diseases professionals and will also attract medical affairs members in global pharmaceutical companies.

这本书描述了由药物引起的肺部损伤的病理条件、监测策略以及如何解读证据的方法。它还深入探讨了导致这种状况的具体药物，如EGFR抑制剂、抗-EGFR抗体、mTOR抑制剂、蛋白酶体抑制剂、免疫检查点抑制剂、新血管生成抑制剂和其他分子靶向药物。它概述了每种药物在监控诱导肺部病变出现弥漫性模糊情况的上市后调查中的分析和解读数据。由于缺乏临床证据和案例，尚无指导性文件建立。随着新药物的研发，制定治疗方案和事件管理变得至关重要。因此，《肿瘤学中由药物引起的肺部障碍—专家意见解析大数据》总结了积累的信息，为进一步的研究发展提供了基础。这本书对当前的医学肿瘤学和呼吸系统疾病的处理方法提供了一个全新的视角，并将吸引全球制药公司的医疗事务成员。

---

Download from free file storage

 Download from nitroflare.com  Download from rapidgator.net

---

我要反馈

---

本站不对文件进行储存，仅提供文件链接，请自行下载，本站不对文件内容负责，请自行判断文件是否安全，如发现文件有侵权行为，请联系管理员删除。